A citation-based method for searching scientific literature

Jennifer Faber, Tamara Schaprian, Koyak Berkan, Kathrin Reetz, Marcondes Cavalcante França, Thiago Junqueira Ribeiro de Rezende, Jiang Hong, Weihua Liao, Bart van de Warrenburg, Judith van Gaalen, Alexandra Durr, Fanny Mochel, Paola Giunti, Hector Garcia-Moreno, Ludger Schoels, Holger Hengel, Matthis Synofzik, Benjamin Bender, Gulin Oz, James Joers, Jereon J de Vries, Jun-Suk Kang, Dagmar Timmann-Braun, Heike Jacobi, Jon Infante, Richard Joules, Sandro Romanzetti, Jorn Diedrichsen, Matthias Schmid, Robin Wolz, Thomas Klockgether. Mov Disord 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Compromised mitochondrial complex II in models of Machado-Joseph disease.
Mário N Laço, Catarina R Oliveira, Henry L Paulson, A Cristina Rego. Biochim Biophys Acta 2012
29
100

Inherited polyglutamine spinocerebellar ataxias in South Africa.
D C Smith, A Bryer, L M Watson, L J Greenberg. S Afr Med J 2012
20
100

Polyglutamine diseases: protein cleavage and aggregation.
H Y Zoghbi, H T Orr. Curr Opin Neurobiol 1999
82
100

Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.
Mateusz de Mezer, Marzena Wojciechowska, Marek Napierala, Krzysztof Sobczak, Wlodzimierz J Krzyzosiak. Nucleic Acids Res 2011
119
100

Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes.
Dominique Helmlinger, Sara Hardy, Souphatta Sasorith, Fabrice Klein, Flavie Robert, Chantal Weber, Laurent Miguet, Noëlle Potier, Alain Van-Dorsselaer, Jean-Marie Wurtz,[...]. Hum Mol Genet 2004
167
100

Trinucleotide repeat disorders.
Harry T Orr, Huda Y Zoghbi. Annu Rev Neurosci 2007
972
100

Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.
Li Fan, Yu Feng, Guo-Chong Chen, Li-Qiang Qin, Chun-Ling Fu, Li-Hua Chen. Pharmacol Res 2017
58
100

Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy.
Christopher J Mann, Kaite Honeyman, Graham McClorey, Sue Fletcher, Stephen D Wilton. J Gene Med 2002
116
100


DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.
Conceição Bettencourt, Davina Hensman-Moss, Michael Flower, Sarah Wiethoff, Alexis Brice, Cyril Goizet, Giovanni Stevanin, Georgios Koutsis, Georgia Karadima, Marios Panas,[...]. Ann Neurol 2016
114
100

Clinical Features of Machado-Joseph Disease.
Nuno Mendonça, Marcondes C França, António Freire Gonçalves, Cristina Januário. Adv Exp Med Biol 2018
7
100

Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice.
Edgardo Rodríguez-Lebrón, Maria do Carmo Costa, Katiuska Luna-Cancalon, Therese M Peron, Svetlana Fischer, Ryan L Boudreau, Beverly L Davidson, Henry L Paulson. Mol Ther 2013
74
100

SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.
K Nakamura, S Y Jeong, T Uchihara, M Anno, K Nagashima, T Nagashima, S Ikeda, S Tsuji, I Kanazawa. Hum Mol Genet 2001
456
100

Viltolarsen: First Approval.
Sohita Dhillon. Drugs 2020
32
100

Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7.
M D Kaytor, L A Duvick, P J Skinner, M D Koob, L P Ranum, H T Orr. Hum Mol Genet 1999
85
100

Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.
Vikas B Palhan, Shiming Chen, Guang-Hua Peng, Agneta Tjernberg, Armin M Gamper, Yuxin Fan, Brian T Chait, Albert R La Spada, Robert G Roeder. Proc Natl Acad Sci U S A 2005
171
100

Impact of Ataxin-2 knock out on circadian locomotor behavior and PER immunoreaction in the SCN of mice.
Martina Pfeffer, Suzana Gispert, Georg Auburger, Helmut Wicht, Horst-Werner Korf. Chronobiol Int 2017
14
100

Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1.
Akifumi Mizutani, Lei Wang, Harini Rajan, Parminder J S Vig, William A Alaynick, Joshua P Thaler, Chih-Cheng Tsai. EMBO J 2005
61
100

Molecular Mechanisms and Therapeutics for SCA17.
Qiong Liu, Yongcheng Pan, Xiao-Jiang Li, Shihua Li. Neurotherapeutics 2019
6
100

Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
Aaron B Bowman, Yung C Lam, Paymaan Jafar-Nejad, Hung-Kai Chen, Ronald Richman, Rodney C Samaco, John D Fryer, Juliette J Kahle, Harry T Orr, Huda Y Zoghbi. Nat Genet 2007
59
100

Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
Isabel Nascimento-Ferreira, Tiago Santos-Ferreira, Lígia Sousa-Ferreira, Gwennaëlle Auregan, Isabel Onofre, Sandro Alves, Noëlle Dufour, Veronica F Colomer Gould, Arnulf Koeppen, Nicole Déglon,[...]. Brain 2011
128
100

Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript.
Loren L Flynn, Chalermchai Mitrpant, Ianthe L Pitout, Sue Fletcher, Steve D Wilton. Mol Ther Nucleic Acids 2018
10
100


Cerebellar ataxia, hemiplegic migraine, and related phenotypes due to a CACNA1A missense mutation: 12-year follow-up of a large Portuguese family.
José Barros, Joana Damásio, Assunção Tuna, Ivânia Alves, Isabel Silveira, José Pereira-Monteiro, Jorge Sequeiros, Isabel Alonso, Alda Sousa, Paula Coutinho. JAMA Neurol 2013
22
100




Calcium channels and migraine.
Daniela Pietrobon. Biochim Biophys Acta 2013
43
100


SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.
E N Burright, H B Clark, A Servadio, T Matilla, R M Feddersen, W S Yunis, L A Duvick, H Y Zoghbi, H T Orr. Cell 1995
461
100

Protein misfolding in neurodegenerative diseases: implications and strategies.
Patrick Sweeney, Hyunsun Park, Marc Baumann, John Dunlop, Judith Frydman, Ron Kopito, Alexander McCampbell, Gabrielle Leblanc, Anjli Venkateswaran, Antti Nurmi,[...]. Transl Neurodegener 2017
208
100

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide.
Eleni Kourkouta, Rudie Weij, Anchel González-Barriga, Melissa Mulder, Ruurd Verheul, Sieto Bosgra, Bas Groenendaal, Jukka Puoliväli, Jussi Toivanen, Judith C T van Deutekom,[...]. Mol Ther Nucleic Acids 2019
19
100



Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.
K Seidel, S Siswanto, M Fredrich, M Bouzrou, E R Brunt, F W van Leeuwen, H H Kampinga, H-W Korf, U Rüb, W F A den Dunnen. Neuropathol Appl Neurobiol 2016
27
100

Spinocerebellar ataxia type 7 in South Africa: Epidemiology, pathogenesis and therapy.
L Watson, D C Smith, J Scholefield, R Ballo, S Kidson, L J Greenberg, M J A Wood. S Afr Med J 2016
4
100


Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.
Lodewijk J A Toonen, Frank Rigo, Haico van Attikum, Willeke M C van Roon-Mom. Mol Ther Nucleic Acids 2017
55
100

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Adriano M de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo,[...]. Front Neurol 2017
31
100

Antisense oligonucleotides: from design to therapeutic application.
Jasmine H P Chan, Shuhui Lim, W S Fred Wong. Clin Exp Pharmacol Physiol 2006
224
100

Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
A R La Spada, Y H Fu, B L Sopher, R T Libby, X Wang, L Y Li, D D Einum, J Huang, D E Possin, A C Smith,[...]. Neuron 2001
177
100

Loss of Drosophila Ataxin-7, a SAGA subunit, reduces H2B ubiquitination and leads to neural and retinal degeneration.
Ryan D Mohan, George Dialynas, Vikki M Weake, Jianqi Liu, Skylar Martin-Brown, Laurence Florens, Michael P Washburn, Jerry L Workman, Susan M Abmayr. Genes Dev 2014
37
100

Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
Lindsay A Becker, Brenda Huang, Gregor Bieri, Rosanna Ma, David A Knowles, Paymaan Jafar-Nejad, James Messing, Hong Joo Kim, Armand Soriano, Georg Auburger,[...]. Nature 2017
233
100

[Autopsy case of SCA2 with Parkinsonian phenotype].
Harumi S Yomono, Hiroshi Kurisaki, Akira Hebisawa, Yoshio Sakiyama, Yuko Saito, Shigeo Murayama. Rinsho Shinkeigaku 2010
7
100

The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.
Conceição Bettencourt, Cristina Santos, Rafael Montiel, Teresa Kay, João Vasconcelos, Patrícia Maciel, Manuela Lima. Eur J Hum Genet 2010
16
100

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Daniel R Scoles, Pratap Meera, Matthew D Schneider, Sharan Paul, Warunee Dansithong, Karla P Figueroa, Gene Hung, Frank Rigo, C Frank Bennett, Thomas S Otis,[...]. Nature 2017
150
100

Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.
Y Trottier, Y Lutz, G Stevanin, G Imbert, D Devys, G Cancel, F Saudou, C Weber, G David, L Tora. Nature 1995
542
100

C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity.
Holly B Kordasiewicz, Randall M Thompson, H Brent Clark, Christopher M Gomez. Hum Mol Genet 2006
96
100


Expandable DNA repeats and human disease.
Sergei M Mirkin. Nature 2007
589
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.